| 영문 | rebound phenomenon | 한글 | 반발현상, 반동현상 |
|---|---|---|---|
| 설명 | 소뇌 기능장애에서 사지의 대항근육 사이의 협조성 상실의 징후로서, 환자에게 양팔을 수평으로 뻗게 하고 그 팔을 강하게 치면 정상인 경우는 곧 원상으로 올리는데 비하여 환자에 있어서는 원위치로 돌아오는 데 몇 번이나 떨게 된다. |
||
| 영문 | heparin | 한글 | 헤파린 |
|---|---|---|---|
| 설명 | 혈액 응고를 막는 작용을 하는 다당류의 황산에스테르. 고등동물의 각종 조직에 널리 분포되어 있으며, 수술 후의 혈전증을 막는 데 쓴다. 혈액응고란 지혈의 한 과정으로 섬유소란 물질을 만들어 내는 과정이다. 이 섬유소는 손상된 혈관의 부위에 작용하여 여러 가지 세포들을 얽어 묶는 역할을 하여 결국 손상된 혈관에서 혈액의 소실을 막는다. 이 섬유소는 트롬빈에 의해 섬유소원에서 전환된다. 헤파린이라는 물질은 이 트롬빈을 억제하는 항트롬빈을 활성화하는 물질이다. |
||
| RT | Rebound Tenderness |
|---|---|
| T/RT | Tenderness/Rebound Tenderness |
| PIR | postinhibition rebound; protein identification resource |
| BH | base hospital; benzalkonium and heparin; bill of health; birth history; Bishop-Harman [instruments];... |
| CH | case history; Chediak-Higashi [syndrome]; chiasma; Chinese hamster; chloral hydrate; cholesterol; Ch... |
| PIR | Postinhibitory rebound |
|---|---|
| LMW heparin | Low Molecular Weight heparin |
| HEP | 1--heparin |
| HSPG | heparin sulfate proteoglycan |
| H | Heparin |
| rebound | Just like a rebound in basketball when the ball reverses its course and bounces back off the backboard, in medicine a rebound is a reversal of response upon withdrawal of the stimulus. (12 Dec 1998) |
|---|---|
| rebound effect | The characteristic of a drug to produce reverse effects when either the effect of the drug has passed or when the patient no longer responds to the drug. (18 Nov 1997) |
| rebound phenomenon | Generally, any phenomenon in which a variable that has been displaced from its normal state by a disturbing influence temporarily deviates from normal in the opposite direction when the disturbing influence is suddenly removed, before finally stabilizing at its normal state, i.e., a phenomenon involving undershoot; e.g., the subsequent hypoglycaemia that may follow injection of glucose, because the initial hyperglycaemia caused excessive secretion of insulin. Synonym: Stewart-Holmes sign (05 Mar 2000) |
| heparin | <drug> Sulphated mucopolysaccharide, found in granules of mast cells, that inhibits the action of thrombin on fibrinogen by potentiating antithrombins, thereby interfering with the blood clotting cascade. Platelet factor IV will neutralise heparin. (18 Nov 1997) |
| heparin antagonists | Coagulant substances inhibiting the anticoagulant action of heparin. (12 Dec 1998) |
| heparin binding growth factor | <growth factor> Acidic fibroblast growth factor (alpha FGF, HBGF 1) and basic FGF (beta FGF, HBGF 2) are the two founder members of a family of structurally related growth factors for mesodermal or neuroectodermal cells. Synonym: heparin binding growth factor. Acronym: FGF (18 Nov 1997) |
| heparin cofactor II | <chemical> A sulfated plasma protein with the mw of approximately 66kda. The protein is an inhibitor of thrombin in plasma that is activated by dermatan sulfate or heparin. It is a member of the serpin superfamily. Pharmacological action: serine proteinase inhibitors. Chemical name: Heparin cofactor II (12 Dec 1998) |
| heparin complement | The protein component of heparin in blood. (05 Mar 2000) |
| heparin eliminase | <enzyme> An enzyme of the isomerase class that catalyses the eliminative cleavage of polysaccharides containing 1,4-linked d-glucuronate or l-iduronate residues and 1,4-alpha-linked 2-sulfoamino-2-deoxy-6-sulfo-d-glucose residues to give oligosaccharides with terminal 4-deoxy-alpha-d-gluc-4-enuronosyl groups at their non-reducing ends. Chemical name: heparin lyase Registry number: EC 4.2.2.7 (12 Dec 1998) |
| heparin-glucosamine 3-O-sulfotransferase | <enzyme> Reaction: 3'-phosphoadenylylsulfate + heparin-glucosamine = adenosine 3',5'-bisphosphate + heparin glucosamine 3-o-sulfate Registry number: EC 2.8.2.23 Synonym: glucosaminyl 3-o-sulfotransferase, d-glucosaminyl 3-o-sulfotransferase (26 Jun 1999) |
| heparin, low-molecular-weight | <chemical> Heparin fractions with a molecular weight usually between 4000 and 6000 kD. These low-molecular-weight fractions are effective antithrombotic agents. Their administration reduces the risk of haemorrhage, they have a longer half-life, and their platelet interactions are reduced in comparison to unfractionated heparin. They also provide an effective prophylaxis against postoperative major pulmonary embolism. Pharmacological action: anticoagulant, fibrinolytic agent. (12 Dec 1998) |
| heparin lyase | <enzyme> An enzyme of the isomerase class that catalyses the eliminative cleavage of polysaccharides containing 1,4-linked d-glucuronate or l-iduronate residues and 1,4-alpha-linked 2-sulfoamino-2-deoxy-6-sulfo-d-glucose residues to give oligosaccharides with terminal 4-deoxy-alpha-d-gluc-4-enuronosyl groups at their non-reducing ends. Chemical name: heparin lyase Registry number: EC 4.2.2.7 (12 Dec 1998) |
| heparin unit | The quantity of heparin required to keep 1 ml of cat's blood fluid for 24 hr at 0캜; it is equivalent approximately to 0.002 mg of pure heparin. Synonym: Howell unit. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|